Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation - A new paradigm for cooperation among prostate tumor cells

International Journal of Cancer

Volumn 121, Issue 6, 2007, Pages 1238-1244

  Lapouge, Gaëlle ^a   Erdmann, Eva ^a   Marcias, Gemma ^a   Jagla, Monika ^a   Monge, Audrey ^a   Kessler, Pascal ^a   Serra, Sebastian ^b   Lang, Hervé ^b   Jacqmin, Didier ^b   Bergerat, Jean Pierre ^a,b   Céraline, Jocelyn ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Androgen receptor mutation; Clonal cooperation; Hormone refractory prostate cancer; Paracrine action; Transcriptional activities

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN RESPONSIVE ELEMENT; ARTICLE; CANCER CELL; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL STRAIN LNCAP; COCULTURE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONSENSE MUTATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN LOCALIZATION;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; CODON, NONSENSE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; PARACRINE COMMUNICATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSFECTION;

EID: 34548089696     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22830     Document Type: Article

References (19)

1. Renaud JP, Moras D. Structural studies on nuclear receptors. Cell Mol Life Sci 2000;57:1748-69.
2. McEwan JJ. Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain. Endocr Relat Cancer 2004;11:281-93.
3. Heinlein CA, Chang C. Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 2002;23:175-200.
4. Ikonen T, Palvimo JJ, Janne OA. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 1997;272:29821-8.
5. He B, Lee LW, Minges JT, Wilson EM. Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem 2002;277:25631-9.
6. Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD, White FM, Christian RE, Settlage RE, Shabanowitz J, Hunt DF, Weber MJ. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 2002;277:29304-14.
7. Taneja SS, Ha S, Swenson NK, Huang HY, Lee P, Melamed J, Shapiro E, Garabedian MJ, Logan SK. Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem 2005;280: 40916-24.
8. Blok LJ, de Ruiter PE, Brinkmann AO. Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry 1998;37:3850-7.
9. Gottlieb B, Beitel LK, Wu JH, Trifiro M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 2004;23:527-33.
10. Hara T, Miyazaki J, Araki H, Yamaoka M, Kanzaki N, Kusaka M, Miyamoto M. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome. Cancer Res 2003; 63:149-53.
11. Duff J, McEwan JJ. Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions. Mol Endocrinol 2005;19:2943-54.
12. Monge A, Jagla M, Lapouge G, Sasorith S, Cruchant M, Wurtz JM, Jacqmin D, Bergerat JP, Ceraline J. Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer. Cell Mol Life Sci 2006;63:487-97.
13. Ceraline J, Cruchant MD, Erdmann E, Erbs P, Kurtz JE, Duclos B, Jacqmin D, Chopin D, Bergerat JP. Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer. Int J Cancer 2004;108:152-7.
14. Ceraline J, Erdmann E, Erbs P, Deslandres-Cruchant M, Jacqmin D, Duclos B, Klein-Soyer C, Dufour P, Bergerat JP. A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer. Eur J Endocrinol 2003;148:99-110.
15. Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J. Androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 1997;11:148-61.
16. Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991;51:105-9.
17. Karnik PS, Kulkarni S, Liu XP, Budd GT, Bukowski RM. Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res 1994;54:349-53.
18. Jia L, Coetzee GA. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Cancer Res 2005;65:8003-8.
19. Culig Z, Steiner H, Bartsch G, Hobisch A. Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours. Endocr Relat Cancer 2005;12:229-44.